Our company has established a commercial-scale production platform for aluminum hydroxide adjuvants for vaccines, with a production capacity of 500,000 doses per batch. The aluminum hydroxide adjuvant we produced features uniform particle size, high purity, excellent safety, stable suspension, strong adsorption capacity, and have been used in the production of marketed products. Additionally, our company has developed preparation technology for high-salt aluminum hydroxide adjuvants with enhanced immunogenicity.